应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GNPX Genprex, Inc.
耶稣受难日休市 03-28 16:00:00 EDT
2.98
+0.27
+9.96%
盘后
2.98
+0.00
0.00%
19:34 EDT
最高
3.02
最低
2.73
成交量
3.00万
今开
2.76
昨收
2.71
日振幅
10.70%
总市值
569.31万
流通市值
559.67万
总股本
191.04万
成交额
8.70万
换手率
1.60%
流通股本
187.81万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Genprex, Inc.盘中异动 快速拉升6.86%
自选股智能写手 · 03-25
Genprex, Inc.盘中异动 快速拉升6.86%
Genprex, Inc.盘中异动 早盘大幅上涨5.03%报3.13美元
自选股智能写手 · 03-21
Genprex, Inc.盘中异动 早盘大幅上涨5.03%报3.13美元
Genprex, Inc.股价重挫11.24% 市值跌10.42万美元
自选股智能写手 · 03-20
Genprex, Inc.股价重挫11.24% 市值跌10.42万美元
Genprex, Inc.盘中异动 早盘大幅下跌6.85%报3.81美元
自选股智能写手 · 03-19
Genprex, Inc.盘中异动 早盘大幅下跌6.85%报3.81美元
Genprex, Inc.盘中异动 早盘股价大涨5.69%
自选股智能写手 · 03-18
Genprex, Inc.盘中异动 早盘股价大涨5.69%
Genprex, Inc.盘中异动 早盘快速下跌6.38%
自选股智能写手 · 03-12
Genprex, Inc.盘中异动 早盘快速下跌6.38%
Genprex, Inc.盘中异动 股价大涨7.12%
自选股智能写手 · 03-11
Genprex, Inc.盘中异动 股价大涨7.12%
Genprex, Inc.盘中异动 早盘大幅下挫5.25%
自选股智能写手 · 03-07
Genprex, Inc.盘中异动 早盘大幅下挫5.25%
Genprex, Inc.盘中异动 早盘大幅下挫5.57%报4.00美元
自选股智能写手 · 03-05
Genprex, Inc.盘中异动 早盘大幅下挫5.57%报4.00美元
Genprex, Inc.盘中异动 下午盘大幅下挫5.13%报4.25美元
自选股智能写手 · 03-05
Genprex, Inc.盘中异动 下午盘大幅下挫5.13%报4.25美元
Genprex, Inc.盘中异动 临近午盘股价大涨5.81%
自选股智能写手 · 03-02
Genprex, Inc.盘中异动 临近午盘股价大涨5.81%
Genprex, Inc.盘中异动 大幅上涨5.04%报4.38美元
自选股智能写手 · 02-29
Genprex, Inc.盘中异动 大幅上涨5.04%报4.38美元
Genprex Inc盘中异动 下午盘快速上涨7.23%报4.60美元
自选股智能写手 · 02-22
Genprex Inc盘中异动 下午盘快速上涨7.23%报4.60美元
Genprex Inc盘中异动 股价大跌5.38%报4.40美元
自选股智能写手 · 02-16
Genprex Inc盘中异动 股价大跌5.38%报4.40美元
Genprex Inc盘中异动 股价大跌5.54%报4.60美元
自选股智能写手 · 02-15
Genprex Inc盘中异动 股价大跌5.54%报4.60美元
Genprex Inc盘中异动 急速跳水7.67%报4.07美元
自选股智能写手 · 02-10
Genprex Inc盘中异动 急速跳水7.67%报4.07美元
Genprex Inc盘中异动 早盘股价大跌5.23%
自选股智能写手 · 02-08
Genprex Inc盘中异动 早盘股价大跌5.23%
Genprex Inc股价飙升23.69% 市值涨257.32万美元
自选股智能写手 · 02-05
Genprex Inc股价飙升23.69% 市值涨257.32万美元
BUZZ-Genprex公司在中期癌症研究中为首例患者投药后股价上涨
Reuters · 02-05
BUZZ-Genprex公司在中期癌症研究中为首例患者投药后股价上涨
加载更多
公司概况
公司名称:
Genprex, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司,为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司,开发一种新的方法来治疗癌症,根据其新的专利技术平台,包括其最初的候选产品,Oncoprex免疫基因治疗提供,或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因,然后静脉内施用并被肿瘤细胞摄取,其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制,其中断细胞信号通路,其引起癌细胞的复制和增殖,重新建立癌细胞中凋亡途径或程序性细胞死亡途径,并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。
发行价格:
--
{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":2.98,"timestamp":1711656000000,"preClose":2.71,"halted":0,"volume":29957,"hourTrading":{"tag":"盘后","latestPrice":2.98,"preClose":2.98,"latestTime":"19:34 EDT","volume":162,"amount":500.59,"timestamp":1711668858883},"delay":0,"floatShares":1878100,"shares":1910441,"eps":-24.26628,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":0.27,"latestTime":"03-28 16:00:00 EDT","open":2.76,"high":3.015,"low":2.725,"amount":87008.77940490001,"amplitude":0.107011,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-24.26628,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"listingDate":1522296000000,"adjPreClose":2.71,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.84,"preClose":2.73,"latestTime":"09:28 EDT","volume":502,"amount":1430.6799199999998,"timestamp":1711632536086},"postHourTrading":{"tag":"盘后","latestPrice":2.98,"preClose":2.98,"latestTime":"19:34 EDT","volume":162,"amount":500.59,"timestamp":1711668858883},"volumeRatio":0.594713},"requestUrl":"/m/hq/s/GNPX","defaultTab":"news","newsList":[{"id":"2422482335","title":"Genprex, Inc.盘中异动 快速拉升6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422482335","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422482335?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:43","pubTimestamp":1711374228,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时43分,Genprex, Inc.股票出现异动,股价大幅上涨6.86%。截至发稿,该股报3.27美元/股,成交量8394股,换手率0.44%,振幅0.00%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1644.31%、54.50%、31.58%,振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Sagimet Biosciences Inc. - Series A,振幅分别为36.42%、19.84%、14.63%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521434887e7b7ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521434887e7b7ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421498260","title":"Genprex, Inc.盘中异动 早盘大幅上涨5.03%报3.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421498260","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421498260?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:35","pubTimestamp":1711028118,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时35分,Genprex, Inc.股票出现波动,股价快速拉升5.03%。截至发稿,该股报3.13美元/股,成交量2868股,换手率0.19%,振幅0.67%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.55%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Portage Biotech Inc.、Argenx Se涨幅较大,Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Xtl生物制药较为活跃,换手率分别为69.68%、14.58%、8.95%,振幅较大的相关个股有Portage Biotech Inc.、Immatics N.V.、Psyence Biomedical Ltd.,振幅分别为23.93%、17.08%、10.17%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213518861e017a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213518861e017a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420164725","title":"Genprex, Inc.股价重挫11.24% 市值跌10.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420164725","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420164725?lang=zh_cn&edition=full","pubTime":"2024-03-20 22:07","pubTimestamp":1710943653,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日22时07分,Genprex, Inc.股票出现波动,股价急速跳水11.24%。截至发稿,该股报3.00美元/股,成交量1.3351万股,换手率0.90%,振幅2.92%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为1.27%。其相关个股中,Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd.、Taysha Gene Therapies, Inc.涨幅较大,Jaguar Health, Inc.、Tc Biopharm Plc、Nls Pharmaceutics Ltd.较为活跃,换手率分别为57.40%、36.00%、26.42%,振幅较大的相关个股有Nls Pharmaceutics Ltd.、Jaguar Health, Inc.、Taysha Gene Therapies, Inc.,振幅分别为33.82%、30.62%、25.16%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202207337a4dfa5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202207337a4dfa5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420227414","title":"Genprex, Inc.盘中异动 早盘大幅下跌6.85%报3.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420227414","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420227414?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:33","pubTimestamp":1710855212,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时33分,Genprex, Inc.股票出现异动,股价大幅跳水6.85%。截至发稿,该股报3.81美元/股,成交量1.0371万股,换手率0.70%,振幅0.00%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.涨幅较大,Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为503.91%、144.75%、119.15%,振幅较大的相关个股有Enveric Biosciences, Inc.、Immuneering Corporation、Lantern Pharma Inc.,振幅分别为23.64%、17.13%、15.85%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319213333861df670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319213333861df670&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420347492","title":"Genprex, Inc.盘中异动 早盘股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420347492","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420347492?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:32","pubTimestamp":1710768750,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时32分,Genprex, Inc.股票出现异动,股价大幅上涨5.69%。截至发稿,该股报4.27美元/股,成交量584股,换手率0.04%,振幅0.00%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm Plc较为活跃,换手率分别为58.69%、11.94%、6.93%,振幅较大的相关个股有2Seventy Bio, Inc.、Elicio Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为12.72%、11.90%、10.64%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213231861df181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213231861df181&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418537585","title":"Genprex, Inc.盘中异动 早盘快速下跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418537585","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418537585?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:32","pubTimestamp":1710250339,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时32分,Genprex, Inc.股票出现异动,股价快速跳水6.38%。截至发稿,该股报4.40美元/股,成交量4.3426万股,换手率2.92%,振幅2.77%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Regulus Therapeutics Inc.、Tracon Pharmaceuticals, Inc.、Tc Biopharm Plc涨幅较大,Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm Plc较为活跃,换手率分别为155.22%、127.81%、27.84%,振幅较大的相关个股有Regulus Therapeutics Inc.、Scorpius Holdings, Inc.、Aslan Pharmaceuticals Limited,振幅分别为47.38%、13.07%、12.26%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321987e782f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321987e782f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418365868","title":"Genprex, Inc.盘中异动 股价大涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418365868","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418365868?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:44","pubTimestamp":1710164676,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时44分,Genprex, Inc.股票出现波动,股价大幅拉升7.12%。截至发稿,该股报4.53美元/股,成交量2596股,换手率0.17%,振幅4.96%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121443679195a0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121443679195a0a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417676239","title":"Genprex, Inc.盘中异动 早盘大幅下挫5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417676239","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417676239?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:30","pubTimestamp":1709821847,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日22时30分,Genprex, Inc.股票出现波动,股价大幅跳水5.25%。截至发稿,该股报4.15美元/股,成交量1.229万股,换手率0.83%,振幅0.23%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Aptevo Therapeutics Inc.、Immuron Limited、Creative Medical Technology Holdings, Inc.较为活跃,换手率分别为169.85%、121.26%、105.15%,振幅较大的相关个股有Creative Medical Technology Holdings, Inc.、Vaxxinity, Inc.、Immuron Limited,振幅分别为23.11%、15.67%、12.12%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307223047861dc453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307223047861dc453&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417177874","title":"Genprex, Inc.盘中异动 早盘大幅下挫5.57%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417177874","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417177874?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:51","pubTimestamp":1709650278,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时51分,Genprex, Inc.股票出现异动,股价大幅跳水5.57%。截至发稿,该股报4.00美元/股,成交量7271股,换手率0.49%,振幅3.54%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.89%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Carmell Corp C/Wts 12/07/2028 、Apogee Therapeutics, Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、CASI制药较为活跃,换手率分别为220.72%、108.60%、55.31%,振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Nrx Pharmaceuticals, Inc.,振幅分别为36.62%、36.02%、32.13%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522511887e761b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522511887e761b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417983173","title":"Genprex, Inc.盘中异动 下午盘大幅下挫5.13%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417983173","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417983173?lang=zh_cn&edition=full","pubTime":"2024-03-05 02:37","pubTimestamp":1709577432,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日02时37分,Genprex, Inc.股票出现异动,股价大幅下挫5.13%。截至发稿,该股报4.25美元/股,成交量2.4478万股,换手率1.65%,振幅8.04%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为2463.04%、555.64%、180.30%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Quoin Pharmaceuticals Ltd、Ocean Biomedical, Inc.,振幅分别为149.44%、103.97%、88.50%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030502371279172304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030502371279172304&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416626876","title":"Genprex, Inc.盘中异动 临近午盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416626876","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416626876?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:45","pubTimestamp":1709311504,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日00时45分,Genprex, Inc.股票出现波动,股价急速上涨5.81%。截至发稿,该股报4.55美元/股,成交量2.4578万股,换手率1.65%,振幅6.28%。Genprex, Inc.股票所在的生物技术行业中,整体涨幅为2.50%。其相关个股中,Biovie Inc.、Adial Pharmaceuticals, Inc、Cardiff Oncology, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为3765.28%、421.90%、365.17%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biovie Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ,振幅分别为102.46%、96.77%、81.48%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403020045047a489c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403020045047a489c8f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415236985","title":"Genprex, Inc.盘中异动 大幅上涨5.04%报4.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415236985","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415236985?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:00","pubTimestamp":1709218809,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日23时00分,Genprex, Inc.股票出现异动,股价急速拉升5.04%。截至发稿,该股报4.38美元/股,成交量9543股,换手率0.64%,振幅6.95%。Genprex, Inc.股票所在的生物技术行业中,整体跌幅为1.26%。其相关个股中,Enveric Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Codexis, Inc.涨幅较大,Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Scisparc Ltd.较为活跃,换手率分别为2235.46%、317.15%、56.85%,振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为104.85%、60.17%、34.76%。Genprex, Inc.公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292300097a48316c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402292300097a48316c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413408888","title":"Genprex Inc盘中异动 下午盘快速上涨7.23%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413408888","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413408888?lang=zh_cn&edition=full","pubTime":"2024-02-22 03:18","pubTimestamp":1708543137,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日03时18分,Genprex Inc股票出现异动,股价大幅上涨7.23%。截至发稿,该股报4.60美元/股,成交量2.5053万股,换手率1.69%,振幅8.16%。Genprex Inc股票所在的生物技术行业中,整体跌幅为0.28%。Genprex Inc公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402220318587a456703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402220318587a456703&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411524790","title":"Genprex Inc盘中异动 股价大跌5.38%报4.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411524790","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411524790?lang=zh_cn&edition=full","pubTime":"2024-02-16 02:45","pubTimestamp":1708022732,"startTime":"0","endTime":"0","summary":"北京时间2024年02月16日02时45分,Genprex Inc股票出现异动,股价快速下跌5.38%。截至发稿,该股报4.40美元/股,成交量2.7001万股,换手率1.82%,振幅3.44%。Genprex Inc股票所在的生物技术行业中,整体涨幅为0.37%。Genprex Inc公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402160245337a43d986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402160245337a43d986&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411337925","title":"Genprex Inc盘中异动 股价大跌5.54%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411337925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411337925?lang=zh_cn&edition=full","pubTime":"2024-02-15 03:32","pubTimestamp":1707939175,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日03时32分,Genprex Inc股票出现波动,股价急速跳水5.54%。截至发稿,该股报4.60美元/股,成交量1.9888万股,换手率1.34%,振幅6.88%。Genprex Inc股票所在的生物技术行业中,整体涨幅为0.71%。其相关个股中,Engene Holdings Inc C/Wts 31/10/2028 Cl A、Engene Holdings Inc、Cogent Biosciences Inc涨幅较大,Adial Pharmaceuticals Inc、Kintara Therapeutics Inc、Azitra Inc较为活跃,换手率分别为162.99%、102.05%、52.71%,振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028 Cl A、Greenwich Lifesciences Inc、Adial Pharmaceuticals Inc,振幅分别为224.76%、61.73%、55.28%。Genprex Inc公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215033256861d5457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215033256861d5457&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410068569","title":"Genprex Inc盘中异动 急速跳水7.67%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410068569","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410068569?lang=zh_cn&edition=full","pubTime":"2024-02-10 00:45","pubTimestamp":1707497152,"startTime":"0","endTime":"0","summary":"北京时间2024年02月10日00时45分,Genprex Inc股票出现波动,股价大幅跳水7.67%。截至发稿,该股报4.07美元/股,成交量4.0917万股,换手率2.75%,振幅6.95%。Genprex Inc股票所在的生物技术行业中,整体涨幅为0.62%。Genprex Inc公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021000455279109a85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021000455279109a85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409717089","title":"Genprex Inc盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409717089","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409717089?lang=zh_cn&edition=full","pubTime":"2024-02-08 22:37","pubTimestamp":1707403052,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日22时37分,Genprex Inc股票出现波动,股价快速下挫5.23%。截至发稿,该股报5.05美元/股,成交量4504股,换手率0.30%,振幅0.75%。Genprex Inc股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Foghorn Therapeutics Inc、Tenaya Therapeutics Inc涨幅较大,Tenax Therapeutics Inc、Biodexa Pharmaceuticals Plc、Invivo Therapeutics Holding Corp较为活跃,换手率分别为400.70%、26.47%、26.27%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Minerva Neurosciences Inc、Keros Therapeutics Inc,振幅分别为29.82%、14.13%、13.89%。Genprex Inc公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020822373287e6f8c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020822373287e6f8c4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409438177","title":"Genprex Inc股价飙升23.69% 市值涨257.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409438177","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409438177?lang=zh_cn&edition=full","pubTime":"2024-02-05 22:32","pubTimestamp":1707143520,"startTime":"0","endTime":"0","summary":"北京时间2024年02月05日22时32分,Genprex Inc股票出现异动,股价急速上涨23.69%。截至发稿,该股报7.31美元/股,成交量55.1469万股,换手率37.11%,振幅13.37%。Genprex Inc股票所在的生物技术行业中,整体涨幅为0.16%。Genprex Inc公司简介:Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205223201816e4b86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205223201816e4b86&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409806144","title":"BUZZ-Genprex公司在中期癌症研究中为首例患者投药后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2409806144","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409806144?lang=zh_cn&edition=full","pubTime":"2024-02-05 22:08","pubTimestamp":1707142081,"startTime":"0","endTime":"0","summary":" 2月5日 - ** 疗法开发商Genprex 股价盘前上涨17.6%至6.95美元 ** 该公司宣布 ,在对其主要候选药物 Reqorsa 进行的一项扩大的中期研究中,该公司已为首例患者用药。** 公司正在测试Reqorsa与阿斯利康公司 的Tagrisso联用治疗晚期非小细胞肺癌患者的疗效** 该研究预计招募约66名患者,主要目标是测试总生存率 ** OS 是指从开始治疗时算起的患者生存期。** Reqorsa 作为一种治疗 NSCLC 和小细胞肺癌的药物,正在其他三项临床试验 中进行测试- GNPX ** 股价在过去 12 个月中下跌了 91.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":-0.2905},{"period":"3month","weight":-0.6761},{"period":"6month","weight":-0.8113},{"period":"1year","weight":-0.9172},{"period":"ytd","weight":-0.6761}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司,为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司,开发一种新的方法来治疗癌症,根据其新的专利技术平台,包括其最初的候选产品,Oncoprex免疫基因治疗提供,或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因,然后静脉内施用并被肿瘤细胞摄取,其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制,其中断细胞信号通路,其引起癌细胞的复制和增殖,重新建立癌细胞中凋亡途径或程序性细胞死亡途径,并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.912357},{"month":2,"riseRate":0.5,"avgChangeRate":0.15537},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.179543},{"month":4,"riseRate":0.333333,"avgChangeRate":0.30806},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.029859},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.075945},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.174388},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032905},{"month":9,"riseRate":0,"avgChangeRate":-0.143387},{"month":10,"riseRate":0,"avgChangeRate":-0.215282},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.138223},{"month":12,"riseRate":0.5,"avgChangeRate":0.020272}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}